Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 19/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7080887 | 0.96 | REN (0.77) | REN | |
| Hydrochloric Acid SCHEMBL6041395 | 0.95 | REN (0.75) | REN | |
| SCHEMBL6041310 | 0.90 | REN (0.73) | REN | |
| Bicarbonate SCHEMBL7547904 | 0.89 | REN (0.80) | REN | |
| Bicarbonate SCHEMBL7553899 | 0.88 | REN (0.73) | REN | |
| SCHEMBL6959162 | 0.88 | REN (0.79) | REN | |
| SCHEMBL27535945 | 0.87 | REN (0.69) | REN | |
| SCHEMBL6041636 | 0.87 | REN (0.80) | REN | |
| SCHEMBL6041909 | 0.87 | REN (0.80) | REN | |
| SCHEMBL6959229 | 0.87 | REN (0.83) | REN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0863875-A1 | NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY | F. HOFFMANN-LA ROCHE AG (CH) | 1998-09-16 | — | — | EP | disclosed |
| WO-1997009311-A1 | NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY | F. HOFFMANN-LA ROCHE AG (CH) | 1997-03-13 | — | — | WO | disclosed |